ok....i bot some.... i'm not sure why........but it is kinda interesting...

The Chertoff Group will advise the Company on general business strategy and operations as well as assist the company in product testing and evaluation, market research and product position, product manufacturing, sales and distribution and other advisory services such as considering capital acquisitions and strategic partnerships. Pursuant to the Agreement, on or prior to September 30, 2009, the Company will grant to the Chertoff Group the right to receive an equity interest in the Company representing ten (10%) percent of the Company's issued and outstanding common shares on a fully diluted basis. While the shareholding is subject to forfeiture, prior to vesting, all of their shares are fully vested if there is a change of control. The shares vest in the following manner: twenty-five (25%) percent on September 1, 2010; twenty-five (25%) percent on September 1, 2011 and fifty (50%) percent on September 1, 2012 provided that the Chertoff Group continues to provide the services through these dates. All of such shares shall fully vest in the event of a change in control of the Company. Under terms of the Agreement, Chertoff Group Principal Jeffrey W. Runge, MD and Deputy Chief Operating Officer Dr. J. Bennet Waters will devote approximately half their time exclusively to advising BioNeutral. Dr. Runge will serve as Senior Medical Advisor, and Dr. Waters will serve as Senior Operations Advisor.